Total raised
$777K
Last: Seed 2018-03
Stage
Seed
Founded
2018
Headcount
2
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
SensoGenic is developing a consumer biosensor based on its patented molecule-allergen interaction and electronic detection technology. The company aims to provide a comprehensive solution for people suffering from food allergies.
Funding history · 1 round · $777K total
2018-03
Seed
$720K
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the current operational status of SensoGenic?
- SensoGenic is currently inactive, having ceased operations in June 2022.
- When was SensoGenic founded?
- SensoGenic was founded in January 2018.
- What technology does SensoGenic develop?
- SensoGenic develops a consumer biosensor based on patented molecule-allergen interaction and electronic detection technology, aiming to provide a solution for food allergies.
- Where is SensoGenic headquartered?
- SensoGenic is headquartered in Rehovot, Israel, at Weizman Street 28.
- What was SensoGenic's last funding round?
- SensoGenic completed a Seed funding round in March 2018, with eHealth Ventures as an investor. For full financing history, refer to startupim.
- Did SensoGenic receive any grants?
- Yes, SensoGenic received a grant of $56,600 from the IIA in April 2019.
- How many employees did SensoGenic have?
- SensoGenic had 2 employees.
- Who are the founders of SensoGenic?
- The founders of SensoGenic are Oded Shoseyov and Alon Yasovsky.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
SensingBiologicals
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2B2C
Highlights
1 PatentsVerified
Tags
diagnosticsnon-invasivedata-analyticssensorsfood-safety-and-traceabilitybiotechnologydetectionallergyconsumer-electronicsdigital-healthcaremobile-applicationsnutrition-advicedigital-therapeuticschronic-patientspatients